NBIXNeurocrine Biosciences, Inc.

$156.58

Is it safe?

Can NBIX take a bad year?

The deepest fall in NBIX's price history on file is −46%; it is −14% below its high today.

8.84

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Annualised volatility
37%

Annualised volatility · roughly twice as jumpy as the market

Worst drawdown on file
−46%

Worst drawdown on file · −14% today

Details
Cash and short-term investments
$1.32B
EBITDA, trailing twelve months
$816M
Operating profit, trailing twelve months
$789M
Annualised volatilitytwo years of daily moves
37%
Worst drawdown on file
−46%
Below its 52-week high
−14%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.